OK
The other posters feel that with your knowledge of the company you might be able to enlighten us on how YOU would have run a biotech company with 4 phase 3 trials on the go in regards to ongoing capital requirements We all understand the last 6 months may not have gone to plan but these decisions were made between 2011 and 2017
And if you can successfully enunciate a plan you would have put in place would you like to run for a board position? We have a desire for constructive ideas that will forward the rapidly developing and changing science which MSB is at the forefront
MSB Holders Only, page-440
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.015(1.56%) |
Mkt cap ! $1.113B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | 99.5¢ | 97.0¢ | $2.315M | 2.360M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 119971 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 24889 | 9 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |